MENU
MDXG
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
MiMedx Group (MDXG) Ownership - Who owns MiMedx Group?
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
1775 West Oak Commons Court, NE
Phone
+1 770 651-9100
Employees
895
Web
https://www.mimedx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.06B
P/E Ratio
24.50
Total Cash
104.42M
Projected Growth
N/A
Total Debt
18.83M
Revenue
348.88M
Risk (Beta)
1.44
Dividend Yield
N/A
Total Cash/Share
0.71
Total Debt/Equity
N/A
Revenue/Share
2.34 USD as % of share price
Fundamentals
MDXG
Capitalization
1.06B
P/E Ratio
24.50
Risk (Beta)
1.44
Dividend Yield
N/A
Total Cash
104M
Total Cash/Share
0.71
Total Debt
18.8M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
2.34%
Revenue
349M
ROE
N/A
Book Value
193M
P/B Ratio
5.24
Cash Flow
N/A
Earnings
0.29
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
147K
Current Ratio
4.21
Current Revenue Per Employee
111000.00
Dividends Per Share - Security
N/A
EBITDA
64.3M
Float
N/A
Float - Current
N/A
Gross Income Margin
81.80
Revenue To Assets
16.87
Shares Held By Institutions
1.21B
Shares Outstanding - Current
147M
Total Liabilities
70.8M
Total Volume MTD
N/A
Value
-1
Gain YTD
-25.572
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a manufacturer of patent protected regenerative biomaterial products and bioimplants
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
1775 West Oak Commons Court, NE
Phone
+1 770 651-9100
Employees
895
Web
https://www.mimedx.com